To ascertain the neutralisation breadth of SARS-CoV-2 binding antibodies, we quantified ACE2 inhibiting Spike and RBD antibodies in the sera obtained at 90, 240 and 360 days post-initial breakthrough infection. Here, ACE2 is linked to infection.